Henry W. Nabeta, Maryam Zahin, J. Fuqua, Elizabeth D. Cash, Ingrid K. Leth, Michael Strauss, J. Novak, Lin Wang, Angela Siegwald, Rachel A. Sheppard, S. Rai, L. Rohan, Sharon Hillier, G. Dryden, Kevin L Potts, K. Palmer
{"title":"评估Q-Griffithsin鼻内预防COVID-19的安全性、可接受性、药代动力学和耐受性的1a/1b期临床试验设计","authors":"Henry W. Nabeta, Maryam Zahin, J. Fuqua, Elizabeth D. Cash, Ingrid K. Leth, Michael Strauss, J. Novak, Lin Wang, Angela Siegwald, Rachel A. Sheppard, S. Rai, L. Rohan, Sharon Hillier, G. Dryden, Kevin L Potts, K. Palmer","doi":"10.55504/2473-2869.1250","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":91979,"journal":{"name":"The University of Louisville journal of respiratory infections","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"A Phase 1a/1b Clinical Trial Design to Assess Safety, Acceptability, Pharmacokinetics and Tolerability of Intranasal Q-Griffithsin for COVID-19 Prophylaxis\",\"authors\":\"Henry W. Nabeta, Maryam Zahin, J. Fuqua, Elizabeth D. Cash, Ingrid K. Leth, Michael Strauss, J. Novak, Lin Wang, Angela Siegwald, Rachel A. Sheppard, S. Rai, L. Rohan, Sharon Hillier, G. Dryden, Kevin L Potts, K. Palmer\",\"doi\":\"10.55504/2473-2869.1250\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":91979,\"journal\":{\"name\":\"The University of Louisville journal of respiratory infections\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The University of Louisville journal of respiratory infections\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55504/2473-2869.1250\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The University of Louisville journal of respiratory infections","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55504/2473-2869.1250","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Phase 1a/1b Clinical Trial Design to Assess Safety, Acceptability, Pharmacokinetics and Tolerability of Intranasal Q-Griffithsin for COVID-19 Prophylaxis